igl

Solar Pharma share value: Siddhartha Khemka hand picks Solar Pharma, Axis Financial institution which may give 14-20% return in a 12 months

[ad_1] The Q2FY23 company earnings to this point have been according to the efficiency of heavyweights comparable to , ,…

2 years ago

igl: IGL’s underperformance could not reverse for now on pricing woes

[ad_1] The stress on working margin of IGL is more likely to stay elevated except the federal government places a…

2 years ago